Amalgamated Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-21,745
| Closed | -$271K | – | 1536 |
|
|
2016
Q4 | $271K | Buy |
21,745
+2,989
| +16% | +$36K | 0.01% | 1194 |
|
|
2016
Q3 | $257K | Buy |
18,756
+27
| +0.1% | +$271 | 0.01% | 1116 |
|
|
2016
Q2 | $190K | Buy |
18,729
+1,135
| +6% | +$8.52K | 0.01% | 1275 |
|
|
2016
Q1 | $112K | Buy |
17,594
+1,514
| +9% | +$8.49K | 0.01% | 1214 |
|
|
2015
Q4 | $101K | Sell |
16,080
-1,545
| -9% | -$10.1K | 0.01% | 1144 |
|
|
2015
Q3 | $103K | Buy |
17,625
+303
| +2% | +$2.33K | 0.01% | 1236 |
|
|
2015
Q2 | $143K | Buy |
17,322
+573
| +3% | +$5.07K | 0.01% | 1285 |
|
|
2015
Q1 | $138K | Buy |
16,749
+649
| +4% | +$4.8K | 0.02% | 897 |
|
|
2014
Q4 | $111K | Buy |
16,100
+24
| +0.1% | +$150 | 0.02% | 829 |
|
|
2014
Q3 | $87K | Sell |
16,076
-7
| -0% | -$41 | 0.01% | 821 |
|
|
2014
Q2 | $102K | Sell |
16,083
-4,752
| -23% | -$32.7K | 0.02% | 845 |
|
|
2014
Q1 | $168K | Sell |
20,835
-155
| -0.7% | -$1.21K | 0.03% | 783 |
|
|
2013
Q4 | $143K | Buy |
20,990
+4,811
| +30% | +$26K | 0.02% | 790 |
|
|
2013
Q3 | $298K | Buy |
+16,179
| New | +$314K | 0.1% | 215 |
|
Other funds holding ARIA
Amalgamated Bank's ARIA Position: Q1 2017 in Review
Amalgamated Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 21,745 shares — an estimated $271K sold.
Amalgamated Bank first reported a position in ARIA in Q3 2013 and held it in 14 quarters. The position peaked at $298K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.
- Amalgamated Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
- Amalgamated Bank sold 21,745 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $271K.
- Amalgamated Bank first reported a position in Ariad Pharmaceuticals Inc in Q3 2013 and held it in 14 quarters.
- Amalgamated Bank's Ariad Pharmaceuticals Inc position peaked at $298K in Q3 2013.
- 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.
Based on Amalgamated Bank's 13F filing for Q1 2017, filed 12 May 2017.